Endovenous thrombolysis in a district hospital using the telestroke system;Trombólisis endovenosa en un hospital comarcal mediante el sistema teleictus

Revista de Neurologia

Volumn 53, Issue 3, 2011, Pages 139-145

  Pedragosa, Àngels ^a,c   Álvarez Sabín, José ^b,c   Molina, Carlos A ^b,c   Brugués, Joan ^a   Ribó, Marc ^b,c  

^a Unit of Systemic Autoimmune Diseases   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Equity; Intra arterial rescue; Ischemic stroke; Telemedicine; Telestroke; Thrombolytic

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN ISCHEMIA; COMMUNITY HOSPITAL; EMERGENCY CARE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEUROLOGIC EXAMINATION; OBSERVATIONAL STUDY; PUBLIC HOSPITAL; STROKE; TELECONSULTATION; TELEMEDICINE; AGED; EMERGENCY HEALTH SERVICE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; EMERGENCY SERVICE, HOSPITAL; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALS, DISTRICT; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; STROKE; TELEMEDICINE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79961060626     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.5303.2010653     Document Type: Article

References (34)

1. Registro de altas de los hospitales del Sistema Nacional de Salud. CMBD. URL: http://www.msps.es/estadEstudios/estadisticas/cmbdhome.htm. [20.08.2010].
2. Álvarez-Sabín J, Alonso de Leciñana M, Gallego J, Gil-Peralta A, Casado I, Castillo J, et al. PASI: Plan de Atención Sanitaria del Ictus. Neurología 2006; 21: 717-26.
3. Dávalos A, Castillo J, Martínez-Vila E. Delay in neurological attention and stroke outcome. Cerebrovascular Diseases Study Group of the Spanish Society of Neurology. Stroke 1995; 26: 2233-7.
4. Álvarez-Sabín J, Molina C, Montaner J, Arenillas J, Pujadas F, Huertas R, et al. Beneficios clínicos de la implantación de un sistema de atención especializada y urgente del ictus. Med Clin (Barc) 2004; 122: 528-31.
5. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke. Cochrane Database Syst Rev 2007; 4: CD000197.
6. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317.
7. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, et al.; SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369: 275-82.
8. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M et al. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke 2003; 34: 1106-13.
9. Ribó M, Álvarez-Sabín J. ¿Puede la telemedicina restablecer la equidad geográfica en el tratamiento del ictus agudo? Rev Neurol 2008; 46: 557-60.
10. Kleindorfer D, Xu Y, Moomaw CJ, Khatri P, Adeoye O, Hornung R. US Geographic distribution of rt-PA utilization by hospital for acute ischemic stroke. Stroke 2009; 40: 3580-4.
11. Egido-Herrero JA, Carneado-Ruiz J. La cadena del ictus: desde el inicio de los síntomas a los Servicios de Urgencias. Rev Neurol 1999; 29: 617-22.
12. Pedragosa A, Álvarez-Sabin J, Molina CA, Sanclemente C, Martín MC, Alonso F, et al. Impact of a telemedicine system on acute stroke care in a community hospital. J Teleme Telecare 2009; 15: 260-3.
13. Ribo M, Molina CA, Pedragosa A, Sanclemente C, Santamarina E, Rubiera M, et al. Geographic differences in acute stroke care in Catalunya: impact of a regional interhospital network. Cerebrovasc Dis 2008; 26: 284-8.
14. Fiorelli M, Bastianello S, Von Kummer R, Del Zoppo GJ, Larrue V, Lesaffre E, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999; 30: 2280-4.
15. Hacke W, Kaste M, Fieschi C, Von Kummer R, Dávalos A, Meier D, et al. Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European- Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-51.
16. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
17. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. Stroke 2000; 31: 2912-9.
18. De Bustos EM, Moulin T, Audebert HJ. Barriers, legal issues, limitations and ongoing questions in telemedicine applied to stroke. Cerebrovasc Dis 2009; 27 (Suppl 4): S36-9.
19. Wang S, Gross H, Lee SB, Pardue C, Waller J, Nichols FT III, et al. Remote evaluation of acute ischemic stroke in rural community hospitals in Georgia. Stroke 2004; 35: 1763-8.
20. Audebert HJ, Kukla C, Clarmann von Claranau S, Kühn J, Vatankhah B, Schenkel J, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005; 36: 287-91.
21. Álvarez-Sabín J, Molina CA, Abilleira S, Montaner J, García- Alfranca F, Jiménez-Fabrega X, et al. Stroke code impact on the efficacy of thrombolytic treatment. Med Clin (Barc) 2003; 120: 47-51.
22. Levine SR, Gorman M. 'Telestroke': the application of telemedicine for stroke. Stroke 1999; 30: 464-9.
23. Demaerschalk BM, Miley ML, Kiernan TE, Bobrow BJ, Corday DA, Wellik KE, et al. Stroke telemedicine. Mayo Clin Proc 2009; 84: 53-64.
24. De Bustos EM, Vuillier F, Chavot D, Moulin T. Telemedicine in stroke: organizing a network-rationale and baseline principles. Cerebrovasc Dis 2009; 27 (Suppl 4): S1-8.
25. Dávalos A, Álvarez-Sabín J, Martí-Vilalta J, Castillo J. Tratamiento intravenoso con activador del plasminógeno tisular en la isquemia cerebral aguda. Med Clin (Barc) 2003; 120: 1-5.
26. García-García J, Gracia-Gil J, Sopelana-Garay D, Ayo-Martín O, Vadillo-Bermejo A, Touza B, et al. Administración de tratamiento trombolítico intravenoso en el ictus isquémico en fase aguda: resultados en el Complejo Hospitalario Universitario de Albacete. Rev Neurol 2008; 46: 7-12.
27. Audebert HJ, Kukla C, Vatankhah B, Gotzler B, Schenkel J, Hofer S, et al. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Stroke 2006; 37: 1822-7.
28. Audebert HJ, Schwamm L. Telestroke: scientific results. Cerebrovasc Dis 2009; 27 (Suppl 4): S15-20.
29. Joubert J, Joubert LB, De Bustos EM, Ware D, Jackson D, Harrison T, et al. Telestroke in stroke survivors. Cerebrovasc Dis 2009; 27 (Suppl 4): S28-35.
30. Tatlisumak T, Soinila S, Kaste M. Telestroke networking offers multiple benefits beyond thrombolysis. Cerebrovasc Dis 2009; 27 (Suppl 4): S21-7.
31. Johansson T, Wild C. Telemedicine in acute stroke management: systematic review. Int J Technol Assess Health Care 2010; 26: 149-55.
32. Audebert HJ, Schenkel J, Heuschmann PU, Bogdahn U, Haberl RL; Telemedic Pilot Project for Integrative Stroke Care Group. Effects of the implementation of a telemedical stroke network: The Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol 2006; 5: 742-8.
33. Seifert M, Ahlbrecht A, Dohmen C, Spuentrup E, Moeller- Hartmann W. Combined interventional stroke therapy using intracranial stent and local intraarterial thrombolysis (LIT). Neuroradiology 2011; 53: 273-82.
34. Cano de la Cuerda R, Muñoz-Hellín E, Alguacil-Diego IM, Molina-Rueda F. Telerrehabilitación y neurología. Rev Neurol 2010; 51: 49-56.